Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11133087rdf:typepubmed:Citationlld:pubmed
pubmed-article:11133087lifeskim:mentionsumls-concept:C0205725lld:lifeskim
pubmed-article:11133087lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:11133087lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:11133087pubmed:issue24lld:pubmed
pubmed-article:11133087pubmed:dateCreated2000-12-29lld:pubmed
pubmed-article:11133087pubmed:abstractTextSubstituted 1,6-naphthyridine derivatives, a new class of human cytomegalovirus inhibitors, were prepared to demonstrate the role of intramolecular hydrogen bonds to maintain the compounds in their active conformation.lld:pubmed
pubmed-article:11133087pubmed:languageenglld:pubmed
pubmed-article:11133087pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133087pubmed:citationSubsetIMlld:pubmed
pubmed-article:11133087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11133087pubmed:statusMEDLINElld:pubmed
pubmed-article:11133087pubmed:monthDeclld:pubmed
pubmed-article:11133087pubmed:issn0960-894Xlld:pubmed
pubmed-article:11133087pubmed:authorpubmed-author:ChanLLlld:pubmed
pubmed-article:11133087pubmed:authorpubmed-author:JinHHlld:pubmed
pubmed-article:11133087pubmed:authorpubmed-author:MauWWlld:pubmed
pubmed-article:11133087pubmed:authorpubmed-author:FalardeauGGlld:pubmed
pubmed-article:11133087pubmed:authorpubmed-author:LavalléeJ FJFlld:pubmed
pubmed-article:11133087pubmed:authorpubmed-author:StefanacTTlld:pubmed
pubmed-article:11133087pubmed:issnTypePrintlld:pubmed
pubmed-article:11133087pubmed:day18lld:pubmed
pubmed-article:11133087pubmed:volume10lld:pubmed
pubmed-article:11133087pubmed:ownerNLMlld:pubmed
pubmed-article:11133087pubmed:authorsCompleteYlld:pubmed
pubmed-article:11133087pubmed:pagination2769-70lld:pubmed
pubmed-article:11133087pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11133087pubmed:meshHeadingpubmed-meshheading:11133087...lld:pubmed
pubmed-article:11133087pubmed:meshHeadingpubmed-meshheading:11133087...lld:pubmed
pubmed-article:11133087pubmed:meshHeadingpubmed-meshheading:11133087...lld:pubmed
pubmed-article:11133087pubmed:meshHeadingpubmed-meshheading:11133087...lld:pubmed
pubmed-article:11133087pubmed:meshHeadingpubmed-meshheading:11133087...lld:pubmed
pubmed-article:11133087pubmed:meshHeadingpubmed-meshheading:11133087...lld:pubmed
pubmed-article:11133087pubmed:meshHeadingpubmed-meshheading:11133087...lld:pubmed
pubmed-article:11133087pubmed:meshHeadingpubmed-meshheading:11133087...lld:pubmed
pubmed-article:11133087pubmed:meshHeadingpubmed-meshheading:11133087...lld:pubmed
pubmed-article:11133087pubmed:year2000lld:pubmed
pubmed-article:11133087pubmed:articleTitleSubstituted 1,6-naphthyridines as human cytomegalovirus inhibitors: conformational requirements.lld:pubmed
pubmed-article:11133087pubmed:affiliationBioChem Pharma Inc., Laval, Québec, Canada.lld:pubmed
pubmed-article:11133087pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:11133087lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11133087lld:pubmed